Cargando…

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial

PURPOSE: The aim of this study was to compare the effect of omeprazole plus mosapride combination therapy with that of omeprazole monotherapy in proton pump inhibitor (PPI) refractory gastroesophageal reflux disease (GERD) patients. PATIENTS AND METHODS: Patients were eligible to participate in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sirinawasatien, Apichet, Kantathavorn, Nontapat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667351/ https://www.ncbi.nlm.nih.gov/pubmed/31440072 http://dx.doi.org/10.2147/CEG.S214677

Ejemplares similares

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
por: Iida, Hiroshi, et al.
Publicado: (2012)

Buccal Buspirone as add–on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD)
por: Abdi, Saeed, et al.
Publicado: (2020)

Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD)
por: Abbasinazari, Mohammad, et al.
Publicado: (2014)

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)
por: Sakurai, Kouichi, et al.
Publicado: (2012)

Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
por: Famouri, Fatemeh, et al.
Publicado: (2020)

Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease
por: Marakhouski, KY, et al.
Publicado: (2017)

Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial
por: Bestebreurtje, Petra, et al.
Publicado: (2020)

Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH
por: Garcia, R.S., et al.
Publicado: (2017)

Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation
por: Hosseini, Mousalreza, et al.
Publicado: (2018)

Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease
por: Karyampudi, Arun, et al.
Publicado: (2017)

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus
por: Kee, Ping Siu, et al.
Publicado: (2022)

Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury
por: Richter, Jute, et al.
Publicado: (2016)

Gaviscon(® )vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial
por: Pouchain, Denis, et al.
Publicado: (2012)

Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study
por: Lim, Hyun Chul, et al.
Publicado: (2013)

Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease
por: Jeon, Hye Kyung, et al.
Publicado: (2022)

Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and gastroesophageal reflux disease in pediatric patients: a review
por: Monzani, Alice, et al.
Publicado: (2010)

Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
por: Mermelstein, Joseph, et al.
Publicado: (2018)

Omeprazole-associated rhabdomyolysis
por: Tanaka, Kumiko, et al.
Publicado: (2014)

¿Omeprazol para todos?
por: Sánchez, Diego P., et al.
Publicado: (2014)

Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis
por: Xia, X. M., et al.
Publicado: (2013)

The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model
por: Tomkovich, Sarah, et al.
Publicado: (2019)

Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
por: Tariq, Muhammad Ali, et al.
Publicado: (2022)

Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect?
por: Monteiro, Rosângela Lucinda Rocha, et al.
Publicado: (2020)

Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
por: Kenngott, S, et al.
Publicado: (2010)

Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole—In Vitro and In Vivo Investigations
por: Betari, Nibal, et al.
Publicado: (2020)

Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
por: Hiromoto, Shiori, et al.
Publicado: (2021)

Omeprazole was safely reused in a rhabdomyolysis patient associated with proton pump inhibitors: A case report
por: Wang, Zhen, et al.
Publicado: (2023)

Drug interaction: Omeprazole and Phenprocoumon
por: Enderle, Christa, et al.
Publicado: (2001)

Induction of Erythrocyte Shrinkage by Omeprazole
por: Naveed, Ayesha, et al.
Publicado: (2020)

Effects of Omeprazole Over Voice Quality in Muscle Tension Dysphonia Patients With Laryngopharyngeal Reflux
por: Kandogan, Tolga, et al.
Publicado: (2012)

Does Omeprazole, the Proton-Pump Inhibitor, Affects the Structure of the Kidney of Male Albino Rats? Histological and Laboratory Study
por: Hussein, Heba M., et al.
Publicado: (2022)

Molecular pathways driving omeprazole nephrotoxicity
por: Fontecha-Barriuso, Miguel, et al.
Publicado: (2020)

A Randomized, Double Blinded, Clinical Trial to Assess the Efficacy and Cost Effectiveness of Omeprazole Compared to Rabeprazole in the Maintenance Therapy of Patients With Gastroesophageal Reflux Disease
por: Park, Jung Ho, et al.
Publicado: (2013)

No effect of omeprazole on pH of exhaled breath condensate in cough associated with gastro-oesophageal reflux
por: Torrego, Alfonso, et al.
Publicado: (2005)

Early Laparoscopic Nissen Fundoplication for Recurrent Reflux Esophagitis: A Cost-Effective Alternative to Omeprazole
por: Nessen, Shawn C., et al.
Publicado: (1999)

Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
por: de Sá, Cláudia Cristina, et al.
Publicado: (2011)

Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
por: Kuipers, E. J., et al.
Publicado: (1999)

Formulation and Evaluation of Omeprazole Tablets for Duodenal Ulcer
por: Choudhury, A., et al.
Publicado: (2010)

Effects of Omeprazole on Iron Absorption: Preliminary Study
por: Tempel, Mila, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4pq4i91aettis3efk8r18ali9a